CDTX News and Press, Cidara Therapeutics Inc. From 11/05/19

SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it will host a Key Opinion Leader (KOL) meeting on its rezafungin and Cloudbreak programs on Novemb...

The following slide deck was published by Cidara Therapeutics, Inc. in conjunction with this Read more ...

SAN DIEGO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it will present three posters at the Infectious Diseases Society of America (IDSA) IDWeek 2019, whi...

WASHINGTON , Oct. 1, 2019 /PRNewswire/ -- The Antimicrobials Working Group (AWG), a coalition of companies with the mission to combat drug-resistant infections and spur life-saving innovations, today announced that eleven of its member companies will present data from their clinical ...

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

The following slide deck was published by Cidara Therapeutics, Inc. in conjunction with this Read more ...

SAN DIEGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that Paul Daruwala, chief operating officer, and James Levine, chief financial officer of Cidara are sc...

Atreca (NASDAQ: BCEL ) initiated with Buy rating and $30 (61% upside) price target at Roth Capital. More news on: Atreca, Inc., Constellation Pharmaceuticals, Inc., Ovid Therapeutics Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Gainers:  Abeona Therapeutics (NASDAQ: ABEO ) +79% . Cidara Therapeutics (NASDAQ: CDTX ) +56% . Ardelyx (NASDAQ: ARDX ) +33% . Quorum Health Corporation (NYSE: QHC ) +21% . Net Element (NASDAQ: NETE ) +19% . Conn's (NASDAQ: CONN ) +18% . Cassava Sciences (NASDAQ: SAVA ) +15% . ...

Thinly traded nano cap Cidara Therapeutics (NASDAQ: CDTX ) is up  77%  premarket on increased volume, albeit in turnover of only 92K shares, in response to its agreement with Mundipharma to develop and commercialize rezafungin, a once-weekly echinocandin antifungal, for the first...